BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 112988
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.112988
Table 2 Comparison of pain control and related outcomes between groups, n (%)
Outcome
EA Group (n = 84)
IVPCA Group (n = 84)
P value
Pain scores (VAS 0-10)
At rest
12 hours2.1 ± 0.84.3 ± 1.1< 0.001
24 hours2.4 ± 0.94.7 ± 1.2< 0.001
48 hours1.9 ± 0.73.8 ± 1.0< 0.001
72 hours1.6 ± 0.63.2 ± 0.9< 0.001
During movement
12 hours4.2 ± 1.36.5 ± 1.5< 0.001
24 hours3.8 ± 1.16.3 ± 1.4< 0.001
48 hours3.3 ± 1.05.4 ± 1.3< 0.001
72 hours2.7 ± 0.94.6 ± 1.2< 0.001
Analgesic consumption
Total opioid consumption (morphine equivalent, mg)32.6 ± 8.468.5 ± 14.7< 0.001
Rescue analgesic requirements14 (16.7)37 (44.0)< 0.001
Analgesia-related adverse effects
Nausea and vomiting16 (19.0)27 (32.1)0.048
Pruritus6 (7.1)14 (16.7)0.031
Hypotension14 (16.7)6 (7.1)0.031
Respiratory depression2 (2.4)5 (6.0)0.246
Urinary retention9 (10.7)7 (8.3)0.601
Patient satisfaction with pain management (0-10)8.3 ± 1.27.1 ± 1.5


Write to the Help Desk